Cheap Diabetes Drug Slashes Risk of Long COVID, Study Finds – ScienceAlert

by

  1. Cheap Diabetes Drug Slashes Risk of Long COVID, Study Finds ScienceAlert
  2. Common drug reduces long COVID, University of Minnesota study shows Star Tribune
  3. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial The Lancet
  4. Study: Using a diabetes medication after testing positive for SARS-CoV-2 reduces risk of developing long COVID by 40% Medical Xpress
  5. New study from UMN researchers says an existing drug is a promising treatment for long COVID MPR News
  6. View Full Coverage on Google News

Read original article here

Leave a Comment